LUNGEKLINIKKEN AS

3015 DRAMMEN

Finances

Share Ownership

Return on Equity

118,82 %

Current Ratio

1,41

Debt-to-Equity Ratio

1,3

Key figures (NOK)	2022	2021	2020	2019
Revenue	13 854 000	10 962 000	9 114 000	6 929 000
Net Income	5 960 000	4 088 000	3 329 000	2 818 000
Total Assets	15 117 000	13 352 000	6 388 000	5 582 000
Total Equity	5 016 000	756 000	1 318 000	989 000

Income (NOK)	2022	2021	2020	2019
Revenue	13 854 000	10 962 000	9 114 000	6 929 000
Expenditure	6 069 000	5 393 000	4 875 000	3 395 000
Operating Profit	7 785 000	5 569 000	4 239 000	3 534 000
Financial Income	208 000	17 000	4 000	57 000
Financial Costs	329 000	209 000	2 000	1 000
Financial Balance	−121 000	−192 000	2 000	56 000
Earnings Before Tax	7 664 000	5 377 000	4 241 000	3 589 000
Tax	1 704 000	1 289 000	912 000	771 000
Net Income	5 960 000	4 088 000	3 329 000	2 818 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	10 082 000	11 916 000	3 063 000	3 696 000
Total Current Assets	5 034 000	1 436 000	3 325 000	1 886 000
Total Assets	15 117 000	13 352 000	6 388 000	5 582 000
Total Retained Equity	4 986 000	726 000	1 288 000	959 000
Total Equity	5 016 000	756 000	1 318 000	989 000
Total Long-Term Debt	6 521 000	7 280 000	600 000	1 005 000
Total Current Debt	3 579 000	5 316 000	4 470 000	3 588 000
Total Equity and Debt	15 117 000	13 352 000	6 388 000	5 582 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	13 128 000	10 569 000	9 000 000	6 929 000
Other Income	726 000	393 000	114 000	0
Revenue	13 854 000	10 962 000	9 114 000	6 929 000
Cost of Goods Sold	2 069 000	2 298 000	2 101 000	1 286 000
Salary Costs	2 559 000	1 835 000	1 794 000	1 366 000
Depreciation	548 000	709 000	521 000	518 000
Impairment	0	0	0	0
Expenditure	6 069 000	5 393 000	4 875 000	3 395 000
Operating Profit	7 785 000	5 569 000	4 239 000	3 534 000
Financial Income	208 000	17 000	4 000	57 000
Financial Costs	329 000	209 000	2 000	1 000
Financial Balance	−121 000	−192 000	2 000	56 000
Dividends	1 700 000	4 650 000	3 000 000	3 597 000
Net Income	5 960 000	4 088 000	3 329 000	2 818 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	83 000	283 000	483 000
Total Intangible Assets	0	83 000	330 000	483 000
Real Eastate	9 064 000	11 307 000	2 055 000	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	319 000	492 000	644 000	965 000
Total Tangible Assets	9 382 000	11 799 000	2 699 000	965 000
Total Fiancial Fixed Assets	700 000	34 000	34 000	2 248 000
Total Fixed Assets	10 082 000	11 916 000	3 063 000	3 696 000
Stock	0	0	0	0
Total Investments	396 000	0	0	0
Cash, Bank	4 611 000	1 428 000	3 303 000	1 829 000
Total Current Assets	5 034 000	1 436 000	3 325 000	1 886 000
Total Assets	15 117 000	13 352 000	6 388 000	5 582 000
Total Equity	5 016 000	756 000	1 318 000	989 000
Short-Term Group Debt	0	0	0	102 000
Total Long-Term Debt	6 521 000	7 280 000	600 000	1 005 000
Creditors	344 000	306 000	182 000	0
Unpaid Taxes	243 000	152 000	140 000	95 000
Dividends	1 700 000	4 650 000	3 000 000	3 597 000
Other Current Debt	288 000	216 000	184 000	107 000
Total Current Debt	3 579 000	5 316 000	4 470 000	3 588 000
Total Equity and Debt	15 117 000	13 352 000	6 388 000	5 582 000

Financial indicators	2022	2021	2020	2019
Return on Equity	118,82 %	540,74 %	252,58 %	284,93 %
Debt-to-Equity Ratio	1,3	9,63	0,46	1,02
Operating Profit Margin	56,19 %	50,8 %	46,51 %	51 %
Current Ratio	1,41	0,27	0,74	0,53
Quick Ratio	1,41	0,27	0,74	0,53
Equity Ratio	0,33	0,06	0,21	0,18
Gross Profit Margin	85,07 %	79,04 %	76,95 %	81,44 %